Results for
"[search-keyword]"
Sponsor content
21 result(s) found, displaying 1 to 10
- AusPAR: CannabidiolAustralian Public Assessment Report (AusPAR)Australian Public Assessment Report for Cannabidiol
- AusPAR: Beclometasone dipropionate/ formoterol fumarate/ glycopyrronium bromideAustralian Public Assessment Report (AusPAR)Australian Public Assessment Report for Beclometasone dipropionate/ formoterol fumarate/ glycopyrronium bromide
- EpidyolexPrescription medicine decision summaryTGA decision: Epidyolex (cannabidiol) is approved as adjunctive therapy for seizures associated with Dravet and Lennox-Gastaut syndrome
- EPIDYOLEX (Emerge Health Pty Ltd)Prescription medicine registrationActive ingredients: cannabidiol.
- AusPAR: Dinutuximab betaAustralian Public Assessment Report (AusPAR)Australian Public Assessment Report for Dinutuximab beta
- TRIMBOW (Emerge Health Pty Ltd)Prescription medicine registrationActive ingredients: beclometasone dipropionate; formoterol (eformoterol) fumarate dihydrate; glycopyrronium bromide (glycopyrrolate).
- QARZIBA (Emerge Health Pty Ltd)Prescription medicine registrationActive ingredients: dinutuximab beta.
- FOSTAIR (Emerge Health Pty Ltd)Prescription medicine registrationActive ingredients: beclometasone dipropionate; formoterol (eformoterol) fumarate dihydrate.